With a market cap of $681.8 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company focused on ...

These five Dow Jones industrial companies have paid dividends to shareholders for at least 100 years, perfect ideas for ...

This was the stock's fifth consecutive day of gains.

The stock's rise snapped a five-day losing streak.

Rising sales of Mounjaro helped Eli Lilly beat expectations for revenue in the most recent quarter. (Sandy Huffaker for The Washington Post/Getty Images) Eli Lilly stock is poised to set a new ...

Eli Lilly’s success with weight-loss drugs has ... has advanced seven straight sessions, according to Dow Jones Market Data.

The Indianapolis-based pharmaceutical company said it expects fourth-quarter revenue of $13.5 billion, around $400 million below the low end of its last estimated range issued in October.

Eli Lilly’s Friday stock gain puts its market capitalization on pace to close above Johnson & Johnson’s for the first time since October 1997, according to Dow Jones Market Data.

Eli Lilly said its Zepbound obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk's Wegovy in a head-to-head study of the two drugs.

Tariffs on pharmaceutical imports could hurt Lilly, especially with its dependence on products made in Ireland. The president ...